@article{251fe8106dc54adb848b90f69c58ad41,
title = "Early phase evaluation of SQ109 alone and in combination with rifampicin in pulmonary TB patients",
abstract = "SQ109, an asymmetrical diamine, is a novel anti-TB drug candidate. This first study in patients was done to determine safety, tolerability, pharmacokinetics and bacteriological effect of different doses of SQ109 alone and in combination with rifampicin when administered over 14 days.",
author = "Norbert Heinrich and Rodney Dawson and {du Bois}, Jeannine and Kim Narunsky and Gary Horwith and Phipps, {Andrew J} and Nacy, {Carol A} and Aarnoutse, {Rob E} and Boeree, {Martin J} and Gillespie, {Stephen H} and Amour Venter and Sonja Henne and Andrea Rachow and Phillips, {Patrick P J} and Michael Hoelscher and Diacon, {Andreas H} and {Pan African Consortium for the Evaluation of Antituberculosis Antibiotics (PanACEA)}",
note = "{\textcopyright} The Author 2015. Published by Oxford University Press on behalf of the British Society for Antimicrobial Chemotherapy. All rights reserved. For Permissions, please e-mail:
[email protected].",
year = "2015",
month = jan,
day = "27",
doi = "10.1093/jac/dku553",
language = "English",
journal = "Journal of Antimicrobial Chemotherapy",
issn = "0305-7453",
publisher = "Oxford University Press",
}